Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Steve Harmon who wrote (2175)	5/11/1999 10:47:00 PM
From: Joe Wesley	Read Replies (4) \| Respond to of 2742

Steve: FWIW: I received a flier today for an IBC Vaccine Summit July 12-14 in Arlington, VA. Monday at 11:30 William Lapps Ph.D. of Pasteur Merieux Connaught is speaking on "IL-1beta as Vaccine Adjuvant; Development and Regulatory Challenges" His presentation will discuss past clinical experiences and animal model testing plans to disassociate the adjuvant effect from the inflammatory effect. Assuming completion of proof of concept in the animal models, plans for preclinical safety testing, delivery system strategies and anticipated clinical trial plans will be presented. AA